Wassenaar Trudy M, Kist Manfred, de Jong Anno
Molecular Microbiology and Genomics Consultants, Tannenstrasse 7, 55576 Zotzenheim, Germany.
Int J Antimicrob Agents. 2007 Sep;30(3):195-201. doi: 10.1016/j.ijantimicag.2007.01.019. Epub 2007 Apr 8.
Recent publications were compared and analysed in addition to novel surveillance data to assess the hypothesis that fluoroquinolone-resistant Campylobacter infections are causing more severe disease than susceptible infections. The available data did not support this hypothesis. There was no significant difference in duration of disease between susceptible and resistant infections. However, both for resistant and susceptible infections, disease symptoms were prolonged by on average 1-2 days for Campylobacter cases acquired during foreign travel. Nevertheless, the likelihood and duration of hospitalisation were not increased for cases related to foreign travel. These observations were confirmed by a new analysis of almost 11,000 cases. We conclude that fluoroquinolone-resistant Campylobacter infections are not more severe than susceptible infections.
除了新的监测数据外,还对近期发表的文献进行了比较和分析,以评估耐氟喹诺酮弯曲杆菌感染比敏感感染导致更严重疾病这一假设。现有数据不支持这一假设。敏感感染和耐药感染在病程上没有显著差异。然而,对于耐药和敏感感染,在国外旅行期间感染弯曲杆菌的病例,其疾病症状平均延长1 - 2天。尽管如此,与国外旅行相关的病例住院的可能性和住院时间并未增加。对近11000例病例的新分析证实了这些观察结果。我们得出结论,耐氟喹诺酮弯曲杆菌感染并不比敏感感染更严重。